Patricia Mjønes

731 total citations
44 papers, 522 citations indexed

About

Patricia Mjønes is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patricia Mjønes has authored 44 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 21 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patricia Mjønes's work include Neuroendocrine Tumor Research Advances (16 papers), Helicobacter pylori-related gastroenterology studies (14 papers) and Gastric Cancer Management and Outcomes (12 papers). Patricia Mjønes is often cited by papers focused on Neuroendocrine Tumor Research Advances (16 papers), Helicobacter pylori-related gastroenterology studies (14 papers) and Gastric Cancer Management and Outcomes (12 papers). Patricia Mjønes collaborates with scholars based in Norway, Sweden and United Kingdom. Patricia Mjønes's co-authors include Helge L. Waldum, Liv Sagatun, Reidar Fossmark, Ivar S. Nordrum, Øystein Sørdal, Hans H. Wasmuth, Jon Erik Grønbech, Erling A. Bringeland, Oriol Calvete and Arne K. Sandvik and has published in prestigious journals such as PLoS ONE, Gut and International Journal of Molecular Sciences.

In The Last Decade

Patricia Mjønes

43 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Mjønes Norway 12 221 192 185 142 101 44 522
Mitsuya Iwafuchi Japan 15 275 1.2× 219 1.1× 170 0.9× 234 1.6× 89 0.9× 29 613
Kazuo Furukawa Japan 11 177 0.8× 98 0.5× 88 0.5× 147 1.0× 43 0.4× 32 509
Haiting Xie China 11 169 0.8× 117 0.6× 80 0.4× 238 1.7× 38 0.4× 30 491
Kazuyuki Kawamoto Japan 10 205 0.9× 71 0.4× 121 0.7× 158 1.1× 21 0.2× 71 447
John H. Gilliam United States 13 277 1.3× 164 0.9× 107 0.6× 97 0.7× 92 0.9× 34 651
Masashi Ishikawa Japan 15 95 0.4× 103 0.5× 284 1.5× 328 2.3× 27 0.3× 47 728
Samuel L. Oyer United States 11 228 1.0× 33 0.2× 66 0.4× 73 0.5× 24 0.2× 39 652
Takeshi Yokoi Japan 9 117 0.5× 78 0.4× 58 0.3× 57 0.4× 28 0.3× 41 488
Emma Howard United Kingdom 12 236 1.1× 74 0.4× 66 0.4× 27 0.2× 85 0.8× 31 682
Petr Jabandžiev Czechia 11 135 0.6× 106 0.6× 38 0.2× 43 0.3× 12 0.1× 60 319

Countries citing papers authored by Patricia Mjønes

Since Specialization
Citations

This map shows the geographic impact of Patricia Mjønes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Mjønes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Mjønes more than expected).

Fields of papers citing papers by Patricia Mjønes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Mjønes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Mjønes. The network helps show where Patricia Mjønes may publish in the future.

Co-authorship network of co-authors of Patricia Mjønes

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Mjønes. A scholar is included among the top collaborators of Patricia Mjønes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Mjønes. Patricia Mjønes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solheim, Ole, et al.. (2025). Merlin immunoreactivity fails to predict neurofibromatosis type 2 mutations in human meningiomas. Journal of Neuropathology & Experimental Neurology. 84(9). 825–830. 1 indexed citations
2.
Klaasen, Rolf Anton, David J. Warren, Nils Bolstad, et al.. (2025). Serological screening for coeliac disease in an adult general population: the HUNT study. Gut. 74(6). 918–925. 1 indexed citations
3.
4.
Koldsland, Odd Carsten, et al.. (2024). Undiagnosed Celiac Disease and Periodontal Bone Loss: A Cross‐Sectional Radiological Assessment from the HUNT Study. International Journal of Dentistry. 2024(1). 1952244–1952244. 1 indexed citations
5.
Mjønes, Patricia, Olav A. Foss, Cato Mørk, et al.. (2024). Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic Therapy. Acta Dermato Venereologica. 104. adv18308–adv18308. 1 indexed citations
6.
7.
Hauso, Øyvind, et al.. (2023). Survival Trends in Patients with Small Intestinal Neuroendocrine Tumours—A Cohort Study in Central Norway. Cancers. 15(13). 3272–3272. 2 indexed citations
8.
Solheim, Ole, et al.. (2023). Meningiomas and Somatostatin Analogs: A Systematic Scoping Review on Current Insights and Future Perspectives. International Journal of Molecular Sciences. 24(5). 4793–4793. 5 indexed citations
9.
Snipstad, Sofie, et al.. (2023). Ultrasound and Microbubbles Increase the Uptake of Platinum in Murine Orthotopic Pancreatic Tumors. Ultrasound in Medicine & Biology. 49(5). 1275–1287. 10 indexed citations
10.
Waldum, Helge L. & Patricia Mjønes. (2023). The central role of gastrin in gastric cancer. Frontiers in Oncology. 13. 1176673–1176673. 11 indexed citations
11.
Fossmark, Reidar, et al.. (2022). Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin?. Medicina. 58(4). 470–470. 3 indexed citations
12.
Wasmuth, Hans H., et al.. (2021). Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours—A Single Centre Cohort. Cancers. 13(16). 3985–3985. 5 indexed citations
13.
Ytterhus, Borgny, et al.. (2021). Somatostatin Receptors in Human Meningiomas—Clinicopathological Aspects. Cancers. 13(22). 5704–5704. 8 indexed citations
14.
Waldum, Helge L., Astrid Kamilla Stunes, Arnar Flatberg, et al.. (2020). Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice. International Journal of Molecular Sciences. 21(3). 927–927. 1 indexed citations
15.
Ness‐Jensen, Eivind, Erling A. Bringeland, Fredrik Mattsson, et al.. (2020). Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population‐based nested case‐control study. International Journal of Cancer. 148(8). 1879–1886. 13 indexed citations
16.
Mjønes, Patricia, et al.. (2017). Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma. Apmis. 125(3). 213–222. 17 indexed citations
17.
Fossmark, Reidar, Shalini V. Rao, Patricia Mjønes, et al.. (2016). PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa. Peptides. 79. 83–94. 7 indexed citations
18.
Sagatun, Liv, Reidar Fossmark, Constantin S. Jianu, et al.. (2016). Follow-up of patients with ECL cell-derived tumours. Scandinavian Journal of Gastroenterology. 51(11). 1398–1405. 9 indexed citations
19.
Christensen, Eidi, et al.. (2014). Diagnostic Accuracy in Subtyping Basal Cell Carcinoma by Clinical Diagnosis Compared with Punch Biopsy. Acta Dermato Venereologica. 96(6). 0–0. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuya Iwafuchi Breakdown of academic impact, for papers by Kazuo Furukawa Breakdown of academic impact, for papers by Haiting Xie Breakdown of academic impact, for papers by Kazuyuki Kawamoto Breakdown of academic impact, for papers by John H. Gilliam Breakdown of academic impact, for papers by Masashi Ishikawa Breakdown of academic impact, for papers by Samuel L. Oyer Breakdown of academic impact, for papers by Takeshi Yokoi Breakdown of academic impact, for papers by Emma Howard Breakdown of academic impact, for papers by Petr Jabandžiev
Rankless by CCL
2026